ReviewCancer drug resistance (Alhambra, Calif.)2026
Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy.
Erhan Da et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewCancer drug resistance (Alhambra, Calif.)2026
Erhan Da et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.